WCM Cell and Cancer Pathobiology Symposium

September 13 - September 14, 2023The WCM Cell and Cancer Pathobiology Symposium is a new series of two-day meetings on fundamental questions on the biology and pathology of cancer. The goal is to create a discussion-friendly type of conference, restricted to about 100-120 participants, in which interactions among speakers and attendees will spark new ideas and potential

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Closing Thoughts on Data Updates From IASLC 2023 World Conference on Lung Cancer

Lipofuscin causes atypical necroptosis through lysosomal membrane permeabilization

Distinct mesenchymal cell states mediate prostate cancer progression

2016: National Acute Stroke Protocol Standard of Care and Emerging Technology-Osborne

The Lancet Commission on diagnostics: transforming access to diagnostics - The Lancet

Cancer Biology Symposia — Moscat & Diaz-Meco Laboratories

Pathology Outlines - Fellowships as of May 3, 2022

Weill Cornell Medicine Pathology and Laboratory Medicine

EP3693023A1 - Use of anti-ceacam5 immunoconjugates for treating lung cancer - Google Patents

Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model

WCM Cell and Cancer Pathobiology Symposium

Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model

State-of-the-Art and Perspectives for Nanomaterials Combined with Nitric Oxide Donors: From Biomedical to Agricultural Applications